Parnassus Investments, LLC Merck & Co., Inc. Transaction History

Parnassus Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $64.5 Million - $70.3 Million	-593,737 Reduced 30.74%	1,337,970 $154 Million
Q4 2022 Jan 30, 2023	SELL	$87.44 - $112.11 $32.8 Million - $42 Million	-374,841 Reduced 16.25%	1,931,707 $214 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $25.3 Million - $31.7 Million	349,615 Added 17.87%	2,306,548 $177 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $17.9 Million - $19.7 Million	249,631 Added 14.62%	1,956,933 $147 Million
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $120 Million - $133 Million	1,707,302 New	1,707,302 $133 Million

3,914

1.94B

15.9M

14M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $214B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parnassus Investments, LLC with notifications on news.